Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$288,100
-$15,150 QoQ
Shares Held
5,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,909
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Morse Asset Management, Inc holds $27,585,966 across 9 Drug Manufacturers - General names. BMY ranks #5 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,610 | $11,526,523 | |
| 2 | JNJ |
Johnson & Johnson
|
26,231 | $6,661,887 | |
| 3 | ABBV |
AbbVie Inc.
|
18,441 | $4,640,493 | |
| 4 | MRK |
Merck & Co., Inc.
|
32,843 | $4,220,325 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
5,000 | $288,100 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,354 | $171,064 | |
| 7 | AMGN |
Amgen Inc
|
200 | $72,424 | |
| 8 | GSK |
GSK plc
|
90 | $4,717 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $288,100 | 5,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $303,250 | 5,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $269,700 | 5,000 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $261,580 | 5,800 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $268,482 | 5,800 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,141,732 | 18,720 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,749,475 | 66,292 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $517,400 | 10,000 | Shares | Sole | 2024-11-20 | |
| 2024-06-30 | $332,240 | 8,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $433,840 | 8,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $410,480 | 8,000 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $464,320 | 8,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $511,600 | 8,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $623,790 | 9,000 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,219,192 | 16,945 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,211,729 | 17,045 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,584,890 | 33,570 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $839,845 | 11,500 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $717,025 | 11,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,033,995 | 17,475 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,167,679 | 17,475 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,134,761 | 17,975 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,894,086 | 30,535 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,846,079 | 30,620 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,665,216 | 28,320 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,341,916 | 42,015 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||